Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Cohen

Showing results (341-350 of 403) with videos related to

Pageof 41
Sort By:
JAMA Cardiology|August 7, 2020
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesNicholas A Marston, Marc P Bonaca, Petr Jarolim, et al.
Journal of the American College of Cardiology|March 26, 2016
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet TherapyMuthiah Vaduganathan, Deepak L Bhatt, Byron L Cryer, et al.
The American Journal of Medicine|May 5, 2016
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT TrialMuthiah Vaduganathan, Christopher P Cannon, Byron L Cryer, et al.
Journal of the American College of Cardiology|August 27, 2016
Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet TreatmentMuthiah Vaduganathan, Deepak L Bhatt, Byron L Cryer, et al.
Journal of the American College of Cardiology|February 7, 2003
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin StudyDeepak L Bhatt, Benjamin I Lee, Peter J Casterella, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trialGregory P Fontana, Ron Waksman, Arash Salemi, et al.
Cancer Cytopathology|April 22, 2026
Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomasJose Manuel Gutierrez Amezcua, Maria E Arcila, Dianna L Ng, et al.
American Heart Journal|October 3, 2002
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensusDean J Kereiakes, Gilles Montalescot, Elliott M Antman, et al.
The American Journal of Cardiology|December 4, 2018
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)Serge Korjian, Yazan Daaboul, François Laliberté, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2002
Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trialJerrold H Levy, Lawrence T Goodnough, Philip E Greilich, et al.
Pageof 41

Showing results (341-350 of 403) with videos related to

Sort By:
Pageof 41
JAMA Cardiology|August 7, 2020
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol GuidelinesNicholas A Marston, Marc P Bonaca, Petr Jarolim, et al.
Journal of the American College of Cardiology|March 26, 2016
Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet TherapyMuthiah Vaduganathan, Deepak L Bhatt, Byron L Cryer, et al.
The American Journal of Medicine|May 5, 2016
Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT TrialMuthiah Vaduganathan, Christopher P Cannon, Byron L Cryer, et al.
Journal of the American College of Cardiology|August 27, 2016
Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet TreatmentMuthiah Vaduganathan, Deepak L Bhatt, Byron L Cryer, et al.
Journal of the American College of Cardiology|February 7, 2003
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin StudyDeepak L Bhatt, Benjamin I Lee, Peter J Casterella, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trialGregory P Fontana, Ron Waksman, Arash Salemi, et al.
Cancer Cytopathology|April 22, 2026
Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomasJose Manuel Gutierrez Amezcua, Maria E Arcila, Dianna L Ng, et al.
American Heart Journal|October 3, 2002
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensusDean J Kereiakes, Gilles Montalescot, Elliott M Antman, et al.
The American Journal of Cardiology|December 4, 2018
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)Serge Korjian, Yazan Daaboul, François Laliberté, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2002
Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trialJerrold H Levy, Lawrence T Goodnough, Philip E Greilich, et al.
Pageof 41